Literature DB >> 8932979

Immunoregulatory cytokines modify Escherichia coli induced uroepithelial cell IL-6 and IL-8 responses.

S R Hedges1, M Bjarnadottir, W Agace, L Hang, C Svanborg.   

Abstract

This study analysed the effects of immunoregulatory cytokines on uroepithelial cell cytokine responses. The A-498 human kidney cell line was treated with the interleukins IL-2, IL-4, IL-5, IL-10, IL-12, IL-13, interferon gamma (IFN-alpha) and transforming growth factor beta (TGF-beta 1). Secreted IL-6 and IL-8 were quantitated by enzyme-linked immunoabsorbent assay (ELISA) and bioassay; IL-6 and IL-8 mRNA species were quantitated by reverse transcriptase polymerase chain reaction (RT-PCR). IL-4, IL-13, IFN-gamma, and TGF-beta 1, but not IL-2, IL-5, IL-10 or IL-12, stimulated IL-6 secretion. At high concentrations, IL-4 and IL-13 stimulated low levels of IL-8 secretion. Immunoregulatory cytokines were analysed for their ability to modify the A-498 cells' IL-6 and IL-8 secretion in response to Escherichia coli. IL-5, IL-12, IL-13 and TGF-beta 1 additively enhanced the bacterially induced IL-6 secretion, but they did not affect IL-8 secretion. The strongest affects on uroepithelial cell IL-6 and IL-8 responses in the presence of bacteria were observed in conjunction with IL-4 and IFN-alpha. IL-4 induced IL-6 production in synergy with E. coli. IFN-alpha both enhanced and inhibited IL-6 and IL-8 responses in combination with E. coli, depending on the order of stimulant addition. The results demonstrate that immunoregulatory cytokines can modify the uroepithelial cell responses to bacteria in vitro. In this way, T cells may regulate the cytokine responses of uroepithelial and possibly other mucosal epithelial cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932979     DOI: 10.1006/cyto.1996.0091

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Urethral cytokine and immune responses in Chlamydia trachomatis-infected males.

Authors:  M S Pate; S R Hedges; D A Sibley; M W Russell; E W Hook; J Mestecky
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

2.  Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa.

Authors:  N Cole; S Bao; M Willcox; A J Husband
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Association of interleukin-10 gene promoter polymorphisms with susceptibility to acute pyelonephritis in children.

Authors:  Juraj Javor; Karol Králinský; Eva Sádová; Oľga Červeňová; Mária Bucová; Michaela Olejárová; Milan Buc; Adriana Liptáková
Journal:  Folia Microbiol (Praha)       Date:  2014-01-22       Impact factor: 2.099

4.  Mycobacterium avium infection of epithelial cells results in inhibition or delay in the release of interleukin-8 and RANTES.

Authors:  F J Sangari; M Petrofsky; L E Bermudez
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Tissue inhibitor of metalloproteinase 1 activates normal human granulocytes, protects them from apoptosis, and blocks their transmigration during inflammation.

Authors:  Milan Chromek; Kjell Tullus; Joachim Lundahl; Annelie Brauner
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection.

Authors:  Thomas J Hannan; Indira U Mysorekar; Chia S Hung; Megan L Isaacson-Schmid; Scott J Hultgren
Journal:  PLoS Pathog       Date:  2010-08-12       Impact factor: 6.823

7.  Enhanced chemokine response in experimental acute Escherichia coli pyelonephritis in IL-1beta-deficient mice.

Authors:  O Hertting; A Khalil; G Jaremko; M Chromek; Y-H Li; M Bakhiet; T Bartfai; K Tullus; A Brauner
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.